We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WULF:NASDAQTeraWulf Inc. Analysis

Data as of 2026-06-07 - not real-time

$24.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

TeraWulf (WULF) is trading at $24, comfortably above its 20‑day ($24.07) and 50‑day ($21.19) simple moving averages, indicating a short‑term bullish bias, while the 30‑day RSI sits near the midpoint at 51.7, suggesting no immediate overbought pressure. Volume is increasing and the price remains above the identified support of $19.60, yet the MACD histogram has turned negative and the signal line is higher than the MACD line, flagging a potential near‑term pullback. The stock’s volatility is extreme at roughly 79% over the past month and its beta exceeds 3, underscoring heightened systematic risk. Fundamentally, the company posts a massive forward PE of 130 versus an industry average of 17, a price‑to‑book of 72, and a price‑to‑sales of 71, all pointing to a heavily overvalued market price relative to earnings and assets. Recent earnings released a GAAP loss of $0.44 per share, far missing consensus, but management highlighted a 117% surge in high‑performance‑computing (HPC) leasing revenue as the business pivots away from volatile Bitcoin mining. With $2.6 B of cash, $5.3 B of debt, no dividend, and a strong‑buy consensus (median target $32), the stock sits at the intersection of speculative upside from the HPC transition and substantial valuation and execution risks.
The technical picture remains mixed: bullish price action and rising volume contrast with bearish MACD momentum and an overbought valuation profile. The extreme‑greed sentiment in the market index reflects investor optimism, but the combination of high beta, elevated volatility, and a sizable earnings miss tempers confidence. In the medium term, the company’s strategic shift could unlock growth, yet the balance sheet strain and inflated multiples keep downside risk pronounced. Investors should weigh the upside from HPC expansion against the near‑term earnings disappointment and the stock’s overvaluation before deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings miss and negative EPS surprise
  • Bearish MACD signal despite price above short‑term averages
  • High volatility and beta increasing downside potential

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Rapid growth in HPC leasing revenue (+117%)
  • Strong analyst consensus (strong_buy) and elevated price targets
  • Substantial cash reserves to fund expansion

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic pivot away from crypto mining reduces regulatory exposure
  • Potential for sustained cash flow generation from high‑performance compute contracts
  • Long‑term upside if valuation compresses as earnings improve

Key Metrics & Analysis

Financial Health

Revenue Growth-1.10%
P/E Ratio129.7
ROE-2215.95%
ROA-3.42%
P/B Ratio71.9
Op. Cash Flow$-197258000
Free Cash Flow$-283343616
Industry P/E17.0

Technical Analysis

TrendBullish
RSI51.7
Support$19.60
Resistance$27.47
MA 20$24.07
MA 50$21.19
MA 200$15.30
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Target Price$36.50
Upside/Downside52.08%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.28
Volatility78.68%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.